Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Public ClinicalTrials.gov record NCT04446312. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.
Study identification
- NCT ID
- NCT04446312
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 13, 2020 (Actual)
- Primary completion
- Jan 7, 2021 (Actual)
- Completion
- Feb 5, 2021 (Actual)
- Last update posted
- Oct 27, 2023
2020 – 2021
United States locations
- U.S. sites
- 34
- U.S. states
- 15
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 302 Research Site 2 | Tucson | Arizona | 85712 | — |
| 302 Research Site 10 | Little Rock | Arkansas | 72211 | — |
| 302 Research Site 11 | North Little Rock | Arkansas | 72117 | — |
| 302 Research Site 9 | Chula Vista | California | 91910 | — |
| 302 Research Site 31 | Los Angeles | California | 90036 | — |
| 302 Research Site 22 | Bristol | Connecticut | 06010 | — |
| 302 Research Site 17 | Fleming Island | Florida | 32003 | — |
| 302 Research Site 3 | Inverness | Florida | 34452 | — |
| 302 Research Site 14 | Jacksonville | Florida | 32256 | — |
| 302 Research Site 28 | Miami | Florida | 33134 | — |
| 302 Research Site 29 | Miami | Florida | 33155 | — |
| 302 Research Site 30 | Miami | Florida | 33155 | — |
| 302 Research Site 38 | Palm Harbor | Florida | 34684 | — |
| 302 Research Site 5 | Oak Lawn | Illinois | 60453 | — |
| 302 Research Site 34 | Baton Rouge | Louisiana | 70809 | — |
| 302 Research Site 26 | Mandeville | Louisiana | 70471 | — |
| 302 Research Site 36 | Monroe | Louisiana | 71201 | — |
| 302 Research Site 16 | Hagerstown | Maryland | 21742 | — |
| 302 Research Site 39 | Brooklyn | New York | 11235 | — |
| 302 Research Site 37 | Great Neck | New York | 11023 | — |
| 302 Research Site 8 | Asheville | North Carolina | 28801 | — |
| 302 Research Site 25 | High Point | North Carolina | 27262 | — |
| 302 Research Site 1 | Raleigh | North Carolina | 27612 | — |
| 302 Research Site 13 | Wilmington | North Carolina | 28403 | — |
| 302 Research Site 18 | Cincinnati | Ohio | 45219 | — |
| 302 Research Site 23 | Jackson | Tennessee | 38305 | — |
| 302 Research Site 33 | Kingsport | Tennessee | 37660 | — |
| 302 Research Site 32 | Cedar Park | Texas | 78613 | — |
| 302 Research Site 21 | Houston | Texas | 77058 | — |
| 302 Research Site 35 | Southlake | Texas | 76092 | — |
| 302 Research Site 27 | Webster | Texas | 77598 | — |
| 302 Research Site 6 | Charlottesville | Virginia | 22911 | — |
| 302 Research Site 4 | Fairfax | Virginia | 22031 | — |
| 302 Research Site 7 | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04446312, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04446312 live on ClinicalTrials.gov.